Rewriting Life Biotech Trial of the Century Could Determine Who Owns CRISPR Attorneys in a dispute over CRISPR gene-editing make their case to patent judges. by Jacob S. Sherkow 2016-12-07T11:49:00-05:00
Rewriting Life CRISPR Dispute to Be Decided by Patent Office A “patent interference” proceeding will determine who controls foundational patents on gene editing. by Jacob S. Sherkow 2016-01-12T11:37:00-05:00